Cargando…

Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer

BACKGROUND: Wingless-type MMTV integration site family member 5A (Wnt5a) has been documented to either overexpress or be lost in several malignancies. Our study aimed to investigate the expression and clinical significance of Wnt5a protein in triple-negative breast cancer (TNBC). MATERIAL/METHODS: B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, ZhenBin, Shan, Ming, Wang, Ji, Liu, Tong, Shi, QingYu, Pang, Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2016
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700863/ https://www.ncbi.nlm.nih.gov/pubmed/26721633 http://dx.doi.org/10.12659/MSM.894821

Ejemplares similares

Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer
por: Shi, Qingyu, et al.
Publicado: (2016)

Analysis of TRRAP as a Potential Molecular Marker and Therapeutic Target for Breast Cancer
por: Wang, Ji, et al.
Publicado: (2016)

Axillary lymph node micrometastases decrease triple-negative early breast cancer survival
por: Houvenaeghel, G, et al.
Publicado: (2016)

Co-activation of Hedgehog and Wnt signaling pathways is associated with poor outcomes in triple negative breast cancer
por: Arnold, Kimberly M., et al.
Publicado: (2017)

Wnt signaling in triple-negative breast cancer
por: Pohl, SÖ-G, et al.
Publicado: (2017)

Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022)

TMPRSS4 as a Poor Prognostic Factor for Triple-Negative Breast Cancer
por: Cheng, Daye, et al.
Publicado: (2013)

Clinicopathological factors associated with novel prognostic markers for patients with triple negative breast cancer
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2018)

Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer
por: Luo, Rong-Zhen, et al.
Publicado: (2013)

The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer
por: He, Min, et al.
Publicado: (2017)

Wnt signaling in triple negative breast cancer is associated with metastasis
por: Dey, Nandini, et al.
Publicado: (2013)

A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer
por: Ma, Fei, et al.
Publicado: (2014)

Upregulated expression of AT-rich interactive domain-containing protein 1B predicts poor prognosis in patients with triple-negative breast cancer
por: Cui, Yan, et al.
Publicado: (2019)

Triple-negative breast cancer: understanding Wnt signaling in drug resistance
por: Merikhian, Parnaz, et al.
Publicado: (2021)

Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma
por: Wang, Ying, et al.
Publicado: (2015)

Identify the triple-negative and non-triple-negative breast cancer by using texture features of medicale ultrasonic image: A STROBE-compliant study
por: Chen, Qingyu, et al.
Publicado: (2021)

Prognostic value of various immune cells and Immunoscore in triple-negative breast cancer
por: Ren, Xinyu, et al.
Publicado: (2023)

Decreased MALL expression negatively impacts colorectal cancer patient survival
por: Wang, Xiaoliang, et al.
Publicado: (2016)

CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy
por: Tokunaga, Eriko, et al.
Publicado: (2018)

AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients
por: Bottai, Giulia, et al.
Publicado: (2016)

The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer
por: Mori, Hitomi, et al.
Publicado: (2017)

Hemorrhage of brain metastasis is a poor prognostic factor in hepatocellular carcinoma patients
por: Lin, Yan, et al.
Publicado: (2017)

Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
por: Liu, Sainan, et al.
Publicado: (2021)

Prognostic significance of GSTP1 in patients with triple negative breast cancer
por: Chen, Guanglei, et al.
Publicado: (2017)

Wnt modulates MCL1 to control cell survival in triple negative breast cancer
por: Yang, Lixin, et al.
Publicado: (2014)

Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
por: Maubant, Sylvie, et al.
Publicado: (2015)

Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT
por: He, Zhen-Yu, et al.
Publicado: (2016)

Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer
por: Ransohoff, Julia D., et al.
Publicado: (2023)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

Prognostic values of EDNRB in triple-negative breast cancer
por: Liu, Shaoqing, et al.
Publicado: (2020)

Oncolytic viruses for triple negative breast cancer and beyond
por: Jin, Shengye, et al.
Publicado: (2021)

Autophagy-related prognostic signature for survival prediction of triple negative breast cancer
por: Yang, Qiong, et al.
Publicado: (2022)

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer
por: Zhao, Zi-Ming, et al.
Publicado: (2019)

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
por: Zhu, Xiuzhi, et al.
Publicado: (2020)

Prognostic Effect of Microenvironment Phenotype in Triple-Negative Breast Cancer: Biomarker Analysis of a Prospective Trial
por: Zhu, Si-Yuan, et al.
Publicado: (2021)

Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis
por: Gu, Yinfang, et al.
Publicado: (2020)

Decreased fertility in poor responder women is not related to oocyte morphological status
por: Nichi, Marcílio, et al.
Publicado: (2011)

Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer
por: O’Shaughnessy, Joyce, et al.
Publicado: (2022)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

Overweight as a Prognostic Factor for Triple-Negative Breast Cancers in Chinese Women
por: Hao, Shuang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fil08r6s4kehn2hdupmn9pi92l